Trials
Search / Trial NCT05651867

EPIONE Guided Lung Evaluation

Launched by QUANTUM SURGICAL · Dec 14, 2022

Trial Information

Current as of February 05, 2025

Completed

Keywords

Percutaneous Ct Guided Ablation Biopsy Abcess Drainage Fiducial Placement Lung Robotics

ClinConnect Summary

The objectives are:

* to evaluate the technical success of the device
* to evaluate performance parameters (accuracy measures, adjustements, post-intervention ablation success, local tumor recurrence)
* to evaluate the safety of the device

25 subjectsare planned and will undergo an intervention, during which the clinician will use the EPIONE device

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient ≥18 years old,
  • Patient for whom a percutaneous CT-guided intervention in lung has been prescribed and agreed by a multidisciplinary team of radiologists, surgeons and clinicians,
  • Patient with a signed informed consent form.
  • Patient covered by a social security system.
  • Exclusion Criteria:
  • Patient unable to undergo general anesthesia,
  • Pregnant or nursing female, confirmed before the intervention
  • Patient already participating in another clinical study

Trial Officials

Baptiste BONNET, MD

Principal Investigator

Gustave Roussy, Cancer Campus, Grand Paris

About Quantum Surgical

Quantum Surgical is a pioneering medical technology company dedicated to advancing minimally invasive surgical solutions through innovative robotic systems. With a strong focus on improving patient outcomes and enhancing surgical precision, Quantum Surgical develops cutting-edge tools that empower healthcare professionals in the treatment of complex conditions. The company is committed to advancing clinical research and fostering collaboration in the medical community, striving to set new standards in surgical care and patient safety. Through rigorous clinical trials and a dedication to innovation, Quantum Surgical aims to transform the landscape of surgical procedures for the benefit of patients worldwide.

Locations

Marseille, , France

Villejuif, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials